← All trials
NCT06622486
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 27, 2024
- Primary completion
- Jan 23, 2027
- Completion date
- Jan 23, 2027
- First posted
- Oct 2, 2024
- Last posted
- Nov 7, 2024
- Enrollment
- 50
- Arms / groups
- 10 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Egle TherapeuticsLead sponsor
- Egle TherapeuticsOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.